Medplus Health Services Ltd (MEDPLUS) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company demonstrated steady operational expansion by adding a net of 117 new stores in the quarter, bringing the total network to 4,930 stores, and remains on track to achieve its target of 600 new store additions for the fiscal year.
- Private label sales constituted a significant 21.5% of total revenues on a GMV basis, with private label pharma sales showing substantial growth to 19.8% from 7.9% in Q1 FY24, indicating successful product adoption.
- The diagnostics segment showed improved profitability, with operating EBITDA margins expanding to 15.3%, driven by increased revenue, although the company is holding off on further CapEx in this segment until subscription numbers reach a target of 250,000.
- The company implemented a new employee retention plan, which led to a notable increase in employee benefit expenses but has successfully reduced attrition by approximately 15% in key cities, aiming to stabilize its workforce.
- Same-store sales growth (SSSG) turned positive at 2.2% after previous negative quarters, with management expressing cautious optimism for a gradual recovery towards high single-digit growth over the next two years, supported by revised incentive plans and supply chain enhancements.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.